Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
5,088
+3
+0.1% +$139 0.02% 201
2026
Q1
$249K Buy
5,085
+3
+0.1% +$140 0.02% 194
2025
Q4
$222K Buy
5,082
+69
+1% +$3.15K 0.02% 202
2025
Q3
$226K Buy
5,013
+3
+0.1% +$132 0.02% 184
2025
Q2
$218K Buy
5,010
+3
+0.1% +$134 0.02% 191
2025
Q1
$231K Sell
5,007
-49
-1% -$2.05K 0.03% 184
2024
Q4
$190K Buy
5,056
+60
+1% +$2.33K 0.02% 196
2024
Q3
$188K Hold
4,996
0.03% 163
2024
Q2
$173K Hold
4,996
0.02% 165
2024
Q1
$188K Hold
4,996
0.03% 165
2023
Q4
$179K Buy
4,996
+3
+0.1% +$116 0.03% 165
2023
Q3
$189K Buy
4,993
+3
+0.1% +$122 0.03% 159
2023
Q2
$203K Buy
+4,990
New +$206K 0.04% 163

Other funds holding EXC

Nemes Rush Group's EXC Position: Q2 2026 in Review

Nemes Rush Group increased its Exelon (EXC) stake by 0.06% in Q2 2026, buying an estimated $139 and bringing the position to 5,088 shares worth $237K. The position accounts for 0.02% of the portfolio, ranked #201.

Nemes Rush Group first reported a position in EXC in Q2 2023 and has held it in 13 quarters since. The position peaked at $249K in Q1 2026. 1,291 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Nemes Rush Group held 5,088 shares of Exelon worth $237K as of Q2 2026.
  • Nemes Rush Group bought 3 Exelon shares in Q2 2026, an estimated $139.
  • Exelon made up 0.02% of Nemes Rush Group's portfolio in Q2 2026, its #201 holding.
  • Nemes Rush Group first reported a position in Exelon in Q2 2023 and has held it in 13 quarters since.
  • Nemes Rush Group's Exelon position peaked at $249K in Q1 2026.
  • 1,291 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.